This drug entry is astuband has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Zinc cation
- DrugBank Accession Number
- DB14532
- Background
-
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
-
Structure for Zinc cation (DB14532)
- Weight
-
Average: 65.409
Monoisotopic: 63.929146578 - Chemical Formula
- Zn
- Synonyms
-
- Zinc ion
- Zinc ion(2+)
- Zinc, ion (Zn2+)
- Zinc(2+)
- Zinc(II)
Pharmacology
- Indication
-
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning models
with evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets. - Associated Conditions
- Contraindications & Blackbox Warnings
-
Avoid life-threatening adverse drug eventsImprove clinical decision support with information oncontraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events & improve clinical decision support. - Pharmacodynamics
-
Not Available
- Mechanism of action
- Not Available
- Absorption
-
Not Available
- Volume of distribution
-
Not Available
- Protein binding
-
Not Available
- Metabolism
- Not Available
- Route of elimination
-
Not Available
- Half-life
-
Not Available
- Clearance
-
Not Available
- Adverse Effects
-
Improve decision support & research outcomesWith structured adverse effects data, including:blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Improve decision support & research outcomes with our structured adverse effects data. - Toxicity
-
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRsBrowse all" title="" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
- Not Available
Interactions
- Drug InteractionsLearn More" title="" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
-
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Integrate drug-drug
interactions in your softwareCabotegravir The serum concentration of Cabotegravir can be decreased when it is combined with Zinc cation. Carbamazepine Zinc cation can cause a decrease in the absorption of Carbamazepine resulting in a reduced serum concentration and potentially a decrease in efficacy. Ceftibuten Zinc cation can cause a decrease in the absorption of Ceftibuten resulting in a reduced serum concentration and potentially a decrease in efficacy. Cephalexin Zinc cation can cause a decrease in the absorption of Cephalexin resulting in a reduced serum concentration and potentially a decrease in efficacy. Cinoxacin Zinc cation can cause a decrease in the absorption of Cinoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Ciprofloxacin Zinc cation can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Deferasirox Zinc cation can cause a decrease in the absorption of Deferasirox resulting in a reduced serum concentration and potentially a decrease in efficacy. Deferiprone Zinc cation can cause a decrease in the absorption of Deferiprone resulting in a reduced serum concentration and potentially a decrease in efficacy. Delafloxacin Zinc cation can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. Demeclocycline Zinc cation can cause a decrease in the absorption of Demeclocycline resulting in a reduced serum concentration and potentially a decrease in efficacy. 
Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.得到严重性评级、描述和管理dvice.Learn more - Food Interactions
- Not Available
Products
-
Drug product information from 10+ global regionsOur datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions. - Mixture Products
-
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Orajel 3X Medicated For Toothache and Gum Zinc cation(1.5 mg/1g)+Benzocaine(200 mg/1g)+Levomenthol(2.6 mg/1g) Gel Topical Church & Dwight Co., Inc. 2019-11-01 Not applicable US 
Orajel 4X Medicated For Toothache and Gum Zinc cation(1.5 mg/1g)+Benzalkonium chloride(1.3 mg/1g)+Benzocaine(200 mg/1g)+Levomenthol(5 mg/1g) Gel Topical Church & Dwight Co., Inc. 2019-11-01 Not applicable US Orajel 4X Medicated For Toothache and Gum, Cream Zinc cation(1.5 mg/1g)+Benzalkonium chloride(1.3 mg/1g)+Benzocaine(200 mg/1g)+Levomenthol(2.6 mg/1g) Cream Topical Church & Dwight Co., Inc. 2019-11-01 Not applicable US Orajel 4X Medicated For Toothache and Gum, Cream Zinc cation(1.5 mg/1g)+Benzalkonium chloride(1.3 mg/1g)+Benzocaine(200 mg/1g)+Menthol(2.6 mg/1g) Cream Topical Church & Dwight Co., Inc. 2019-11-01 Not applicable US Orajel 4X Medicated PM For Toothache and Gum Zinc cation(1.5 mg/1g)+Benzalkonium chloride(1.3 mg/1g)+Benzocaine(200 mg/1g)+Levomenthol(2.6 mg/1g) Cream Topical Church & Dwight Co., Inc. 2019-11-01 Not applicable US
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 13S1S8SF37
- CAS number
- 23713-49-7
- InChI Key
- PTFCDOFLOPIGGS-UHFFFAOYSA-N
- InChI
-
InChI=1S/Zn/q+2
- IUPAC Name
-
zinc(2+) ion
- SMILES
-
[Zn++]
References
- General References
- Not Available
- External Links
- PDB项
- 12ca/1a0b/1a0q/1a1f/1a1g/1a1h/1a1i/1a1j/1a1k/1a1l… show 20639 more
Clinical Trials
- Clinical TrialsLearn More" title="" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
-
Phase Status Purpose Conditions Count
Pharmacoeconomics
- Manufacturers
-
Not Available
- Packagers
-
Not Available
- Dosage Forms
-
Form Route Strength Gel Topical Cream Topical Tablet, delayed release Oral 10 mg Capsule Oral 15 mg Tablet 25 mg Tablet, film coated Oral 25 mg - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
-
Property Value Source logP 0.16 Chemaxon pKa (Strongest Acidic) 3.09 Chemaxon Physiological Charge 2 Chemaxon Hydrogen Acceptor Count 0 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 0 Å2 Chemaxon Rotatable Bond Count 0 Chemaxon Refractivity 0 m3·mol-1 Chemaxon Polarizability 1.78 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule Yes Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
-
Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS splash10-03di-9000000000-0cd08967c771fb645329 Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS splash10-03di-9000000000-0cd08967c771fb645329 Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS splash10-03di-9000000000-0cd08967c771fb645329 Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS splash10-03di-9000000000-29976d3ebd17b2d11a4b Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS splash10-03di-9000000000-29976d3ebd17b2d11a4b Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS splash10-03di-9000000000-29976d3ebd17b2d11a4b
Drug created at July 12, 2018 19:44 / Updated at May 05, 2022 18:00